Company intelligence / Profile preview

Boule Diagnostics

Stockholm (Spånga), Sweden

Ownership: Private
Development stage: Other

Overview

Boule Diagnostics is an established global diagnostics company with over 60 years of heritage in hematology testing[1]. The company manufactures and markets fully automated hematology analyzers and clinical chemistry analyzers for both human and veterinary diagnostics markets[1][2]. Their systems are designed for decentralized point-of-care testing in small and medium-sized hospitals, clinics, and physician office laboratories[1].

Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Over 200 distributors in more than 100 countries

Beyond the preview

Go deeper on Boule Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boule Diagnostics.

Explore the full profile